## Abstract ## Background The majority of the trials in the elderly are outpatient trials which excluded psychotic patients and patients with common comorbid physical disorders. Consequently information is lacking about the more complex cases of elderly depressed patients, as found in inpatient wa
Comparison study of venlafaxine and paroxetine for the treatment of depression in elderly Chinese inpatients
β Scribed by Jen-Ping Hwang; Cheng-Hung Yang; Shih-Jen Tsai
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 37 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.1051
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Paroxetine is a potent selective serotonin reuptake inhibitor (SSRI) with indications for the treatment of depression, obsessiveβ compulsive disorder, panic disorder and social phobia. It is also used in the treatment of generalized anxiety disorder, postβtraumatic stress disorder, prem
## Abstract ## Objective Distinct clinical entities, with and without delusions, have been reported for depressed patients. This study explores the clinical and phenomenological aspects of delusional and nonβdelusional major depression in elderly Chinese patients. ## Methods A total of 156 depre
Objectives. To compare the ecacy of paroxetine and imipramine prospectively in patients with coexisting depression and dementia. Methods. An 8-week, double-blind, parallel group trial comparing paroxetine 20Β±40 mg/day with imipramine 50Β±100 mg/day in 198 patients aged 60 years or over with a Montgo